Mohammad O. Atiq, Walter Michael Stadler, Ashley Page, Meghan Catenacci, Akash Patnaik, Gladell P Paner, Scott Eggener, Russell Zelig Szmulewitz. "Neoadjuvant androgen deprivation therapy with enzalutamide plus the glucocorticoid receptor modulator relacorilant versus placebo for patients with high-risk localized prostate cancer.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.5_suppl.tps436